Highlighted with 88 tables and 111 figures, this 193-page report “Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
"Access Critical Market Data And Analysis For Free - Download Our Sample Report Now!" https://marketdatalibrary.com/download-sample/3974
Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Region.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
"Ready To Elevate Your Reporting Game? Customize Your Report With Just A Few Clicks!" https://marketdatalibrary.com/free-customization/3974
Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Small Molecules
- Large Molecules
o LC-MS Studies
o Immunoassays
o Other Large Molecule Tests
Based Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Bioavailability and Bioequivalence Studies
- Pharmacokinetics (PK)
- Pharmacodynamics (PD)
- Absorption, Distribution, Metabolism, Excretion (ADME)
- Other Applications
By Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Cell-based Assays
o Bacterial Cell-based Assays
o Viral Cell-based Assays
- Virology Testing
o In Vitro Virology Testing
o In Vivo Virology Testing
o Species-Specific Viral PCR Assays
- Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
o Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
o Viral Serology, Immunogenicity, and Neutralizing Antibodies
- Method Development Optimization and Validation (MDOV)
- Biomarker Testing
- Pharmacokinetic Testing
- Other Test Types
By Workflow Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Sample Preparation
o Protein Precipitation
o Liquid-liquid Extraction (LLE)
- Sample Analysis
o Hyphenated Technique
o Chromatographic Technique
o Electrophoresis
o Ligand Binding Assay
o Mass Spectrometry
o Nuclear Magnetic Resonance
- Other Workflow Processes
By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Oncology
- Neurology
- Infectious Diseases
- Gastroenterology
- Cardiology
- Other Therapeutic Areas
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Pharma and Biopharma Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Contract Research Organizations (CROs)
Geographically, the following regions together with the listed national/local markets are fully investigated:
- North America (U.S., Canada, and Mexico)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included.
"Ready To Take Your Business To The Next Level? Talk To Our Industry Expert Today!" https://marketdatalibrary.com/talk-to-consultant/3974
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd.
Read the Complete Report and TOC with Latest Developments: https://marketdatalibrary.com/report-store/global-bioanalytical-testing-services-market-3974
View Other Regional Reports Related to Bioanalytical Testing Services Industry:
North America Bioanalytical Testing Services Market Research Report 2022-2032
Europe Bioanalytical Testing Services Market Research Report 2022-2032
Asia Pacific Bioanalytical Testing Services Market Research Report 2022-2032
About Market Data Library:
Market Data Library is committed to providing clients with high-quality market research that is tailored to their specific needs. The Market Data Library provides corporate intelligence studies that ensure reliable and accurate research data across a diverse range of industries, including Health Care, Chemicals, Packaging, ICT, Automotive, Industrial Automation, Agriculture, and Finance. Our team is comprised of various departments, including sales, operations, finance, research, and analytics, as well as the scientist and data scientist teams. Our business offerings portray the most up-to-date, rational information a company needs to compete effectively. To guarantee that our clients have access to information and insights whenever they need them, we provide 24/7 research support.
Contact Us
Market Data Library
Tel: +1-(718)-312-8686
Email: [email protected]
Website: marketdatalibrary.com/
The Bioanalytical Testing Services Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the bioanalytical testing services market include Pharmaceutical Product Development, LLC.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Bioanalytical Testing Services Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/bioanalytical-testing-services-market/download-sampleMarket DynamicsThe global bioanalytical testing services market is expanding at a fast pace due to the growing pharmaceutical and biopharmaceutical industry.
The significant growth in bioanalytical testing is attributed to increasing concentration on the analytical testing of biosimilars and biologics, increased applications in clinical trials, a growing trend of outsourcing analytical testing.
During the global pandemic COVID0-19 market the bioanalytical testing market is expected to witness prominent growth as the entire healthcare system across the globe is focused on the discovery and development of effective drug solutions to combat the disease.
Global Bioanalytical Testing Services Market Research Report: By Molecule Type (Small Molecule, Large Molecule), By Test Type (Pharmacokinetics, Pharmacodynamics, Bioanalysis, Bioequivalence, Others) - Forecast to 2023The global bioanalytical testing services market is expected to touch a valuation of USD 1,867.30 million by 2023, as per the latest report by Market Research Future (MRFR).
Rising research and development activities conducted in biotechnology and pharmaceutical sectors can spur market growth.Increasing development of biologics can induce market demand over the forecast period.
Patent expiry of various drugs and need for them to expedite clinical trials can positively impact the bioanalytical testing services market.
Outsourcing of testing services to contract research organizations (CROs) in developing economies to curtail operational expenditure costs can propel market growth over the forecast period.Rising prevalence of cancer and other chronic ailments which require blockbuster drugs can bolster market demand in the forthcoming years.
It can touch a size of USD 467.25 million by 2023.
PK assumed the second position by capturing close to 25% share in the same year.
